Aug 8
|
Abbott's EPD Growth Beats Market Trends: Here's How to Play the Stock
|
Aug 8
|
GSK to Receive $370 Million From CureVac, BioNTech Patent Dispute Settlement
|
Aug 8
|
GSK to be paid up to £370 million after patent row settles in US
|
Aug 8
|
Trending tickers: Nvidia, Intel, The Trade Desk, Pinterest and GSK
|
Aug 8
|
GSK to Receive $370 Million in U.S. Patent Litigation Settlement
|
Aug 8
|
Pfizer (PFE) Releases Financial Results for Q2 2025
|
Aug 7
|
Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma
|
Aug 7
|
United States Vaccines Market Insights and Forecasts 2024 & 2025-2033 | Rising Infectious Disease Burden, Robust Funding and Regulatory Support Accelerate Innovation
|
Aug 7
|
United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
|
Aug 7
|
RFK Jr’s mRNA funding halt signals “shift in US public health”
|
Aug 7
|
Arvinas, Pfizer reworking partnership on ‘Protac’ cancer drug
|
Aug 7
|
This 7% Yielding Stock Just Raised Its Profit Forecast. Is It Time to Buy?
|
Aug 6
|
Chai Discovery Announces $70 million Series A To Transform Molecular Design
|
Aug 6
|
Pfizer CEO says has spoken with Trump, in ‘productive’ talks with government
|
Aug 6
|
Why Zoetis (ZTS) is a Top Growth Stock for the Long-Term
|
Aug 6
|
Company News for Aug 6, 2025
|
Aug 6
|
BMY Stock Trades Near 52-Week Low: Time to Buy or Sell?
|
Aug 6
|
Pfizer Second Quarter 2025 Earnings: Beats Expectations
|
Aug 6
|
Nxera debuts an obesity pipeline; BridgeBio battles Alnylam for market share
|
Aug 6
|
1 Reason to Buy Pfizer (PFE) Stock
|